Astrana signals mid-teens adjusted EBITDA growth into 2027
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: Astrana Health (ASTH) Q3 2026 MANAGEMENT VIEW * "Astrana delivered another strong quarter, driven by continued growth, margin expansion and disciplined execution across the business." (President & CEO Brandon Sim) Sim reported record "revenue in the third…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishRecord results and EBITDA growth guidance matter for the stock, against an expected Medicaid membership decline.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Astrana reported record Q3 2026 revenue of $1.02 billion.
- 02Record adjusted EBITDA was $77.2 million.
- 03Adjusted diluted EPS was $0.71.
- 04A 10%-15% Medicaid membership decline is forecast.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets